Respiratory Metagenomics Expansion Programme to Oxford Nanopore Technologies PLC

{
  "awards": [
    {
      "id": "079107-2025-1",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-168166",
          "name": "Oxford Nanopore Technologies Limited"
        }
      ]
    }
  ],
  "bids": {
    "statistics": [
      {
        "id": "3",
        "measure": "bids",
        "relatedLot": "1",
        "value": 1
      },
      {
        "id": "4",
        "measure": "smeBids",
        "relatedLot": "1",
        "value": 0
      },
      {
        "id": "5",
        "measure": "foreignBidsFromEU",
        "relatedLot": "1",
        "value": 0
      },
      {
        "id": "6",
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "1",
        "value": 0
      },
      {
        "id": "7",
        "measure": "electronicBids",
        "relatedLot": "1",
        "value": 0
      },
      {
        "currency": "GBP",
        "id": "1",
        "measure": "lowestValidBidValue",
        "relatedLot": "1",
        "value": 7010966.0
      },
      {
        "currency": "GBP",
        "id": "2",
        "measure": "highestValidBidValue",
        "relatedLot": "1",
        "value": 7010966.0
      }
    ]
  },
  "buyer": {
    "id": "GB-FTS-9768",
    "name": "Guy\u0027s and St Thomas\u0027 NHS Foundation Trust"
  },
  "contracts": [
    {
      "awardID": "079107-2025-1",
      "dateSigned": "2025-11-21T00:00:00Z",
      "id": "079107-2025-1",
      "status": "active"
    }
  ],
  "date": "2025-12-02T17:05:51Z",
  "description": "The Trust has been in contract with Oxford Nanopore for a period of 1 year as part of the pilot programme for delivery of an initial pilot metagenomics service at 9 NHS sites in 2024/25. \u003cbr/\u003eA number of collaboration agreements have existed between GSTT and ONT prior to this, under which the two institutions developed the joint elements of our respective components of the end to end workflow.\u003cbr/\u003eGiven the requirement to continue the pilot arrangements and the continuation of the grant funding from DSIT and OLS, it was necessary to engage in direct negotiations with Oxford Nanopore. In addition, the technology under development is patented and GSTT are working in collaboration with Oxford Nanopore to continue to develop the protocols and undertake the research activity.\u003cbr/\u003eUnder PA23 there are 2 relevant provisions for a direct award for patented technology covered under section 41, Schedule 5. (1) \u201ca supplier is in possession of IP and there are no reasonable alternatives\u2026\u201dand (2) \u201cthe absence of competition for technical reasons\u201d, both sectioned under \u201cSingle Suppliers\u201d where a particular supplier owns the intellectual rights and is the only supplier able to provide that product / service.",
  "id": "079107-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-05ed66",
  "parties": [
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "SE1 9RT",
        "region": "UKI44",
        "streetAddress": "Great Maze Pond"
      },
      "contactPoint": {
        "email": "s.gelinas@nhs.net",
        "name": "Simone Gelinas"
      },
      "details": {
        "buyerProfile": "https://www.lpp.nhs.uk/",
        "classifications": [
          {
            "description": "Body governed by public law",
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE"
          },
          {
            "description": "Health",
            "id": "07",
            "scheme": "COFOG"
          }
        ],
        "url": "https://www.lpp.nhs.uk/"
      },
      "id": "GB-FTS-9768",
      "identifier": {
        "legalName": "Guy\u0027s and St Thomas\u0027 NHS Foundation Trust"
      },
      "name": "Guy\u0027s and St Thomas\u0027 NHS Foundation Trust",
      "roles": [
        "buyer",
        "reviewBody"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Oxfordshire",
        "postalCode": "OX4 4DQ",
        "region": "UKJ14",
        "streetAddress": "Gosling Building Edmund Halley Road, Oxford Science Park"
      },
      "contactPoint": {
        "telephone": "+44 7879896025"
      },
      "details": {
        "scale": "large",
        "url": "http://nanoporetech.com"
      },
      "id": "GB-FTS-168166",
      "identifier": {
        "id": "05386273",
        "legalName": "Oxford Nanopore Technologies Limited"
      },
      "name": "Oxford Nanopore Technologies Limited",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "classification": {
      "description": "Miscellaneous medical devices and products",
      "id": "33190000",
      "scheme": "CPV"
    },
    "description": "The delivery of a National NHS Respiratory Metagenomics Expansion Programme to a network of 30 NHS sites across the UK.",
    "id": "C395947 (Ref # 5940-26)",
    "items": [
      {
        "additionalClassifications": [
          {
            "description": "Medical consumables",
            "id": "33140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKI44"
          }
        ],
        "deliveryLocation": {
          "description": "Guys and St. Thomas Hospital"
        },
        "id": "1",
        "relatedLot": "1"
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "type": "price"
            }
          ]
        },
        "description": "Direct Award. The Trust has been granted funding from the Department of Science, Innovation and Technology (DSIT), with oversight delegated to the Office of Life Sciences (OLS), for the delivery of the NHS Respiratory Metagenomics Expansion Programme, in which GSTT will lead the development of a national clinical metagenomics pilot service by deploying NHS developed laboratory, bioinformatic and clinical protocols along with ONT developed sequencing technology to a network of 30 NHS sites across the UK for the dual benefit of patient care and bio-surveillance. \u003cbr/\u003eThe contract period is for Three Years and will expire on 20th November 2028. The approximate lifetime value of the contract is \u003cbr/\u003eThe contract will be grant funded from the DSIT award to GSTT for the NHS Respiratory Metagenomics Expansion Programme.",
        "hasOptions": false,
        "id": "1",
        "status": "cancelled"
      }
    ],
    "mainProcurementCategory": "goods",
    "procurementMethod": "limited",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "Direct award justification\u003cbr/\u003eSingle supplier - intellectual property or exclusive rights\u003cbr/\u003eIn accordance with Section 41 and Schedule 5 of the PA23, this direct award is to be\u003cbr/\u003emade on the grounds of absence of competition for technical reasons as the products and\u003cbr/\u003eservices are subject to patented technology by Oxford Nanpore Technologies PLC. \u003cbr/\u003eIt is unique in that it is the only sequencing technology available on the market that enables\u003cbr/\u003edirect, real-time analysis of short to ultra-long fragments of DNA/RNA, in fully scalable\u003cbr/\u003eformats. No other provider is able to supply equivalent goods or services.\u003cbr/\u003e\u2022 Additional Information - The contracting authority has concluded that the conditions for a\u003cbr/\u003edirect award are satisfied due to their being no alternatives and an absence of competition\u003cbr/\u003edue to patent status of the required products and services. A Contract Award Notice\u003cbr/\u003e(UK6) will be published following the expiry of the standstill period.",
    "procurementMethodRationaleClassifications": [
      {
        "description": "The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons",
        "id": "D_TECHNICAL",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
      }
    ],
    "status": "complete",
    "title": "Respiratory Metagenomics Expansion Programme to Oxford Nanopore Technologies PLC"
  }
}